Press release
Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports
Commercializing Biomarkers in Therapeutic and Diagnostic Applications MarketThe global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market was valued at US$ 22500 million in 2022 and is anticipated to reach US$ 29810 million by 2029, witnessing a CAGR of 4.8% during the forecast period 2023-2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-5U12923/Global_Commercializing_Biomarkers_in_Therapeutic_and_Diagnostic_Applications_Market_Research_Report_2023
Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market
A biomarker is, according to the US National Institutes of Health, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention."
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market include Roche, Dako (Agilent Technologies), Affymetrix, etc. The top 3 players occupy about 10% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Consumables is the main type, with a share about 60%. The main applications include Oncology, Cardiology, Neurology, etc.
By Type
• Consumables
• Services
• Software
By Application
• Oncology
• Cardiology
• Neurology
• Other
Key Players
Roche, Dako (Agilent Technologies), Merck, BD, Abbott, Genesys Biolabs (20/20GeneSystems), Affymetrix, Agendia, ALMAC, Arrayit, Biocartic, BG Medicine, KEGG EXPRESSION Database, Thermo Fisher, BGI
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-5U12923/global-commercializing-biomarkers-in-therapeutic-and-diagnostic-applications
Similar Reports:
1. https://reports.valuates.com/market-reports/QYRE-Auto-10M7912/global-parp-inhibitor-biomarkers-testing-product
2. https://reports.valuates.com/market-reports/QYRE-Auto-36K9928/global-cardiac-marker-testing-kits
3. https://reports.valuates.com/market-reports/QYRE-Auto-3E3424/global-tumor-biomarker-test
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Email Id:
Please reach us at sales@valuates.com
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports here
News-ID: 3210047 • Views: …
More Releases from Valuates Reports
AI-Powered Pathology Market Size, Revenue Share, Insights & Future Outlook
AI-Powered Pathology Market Size
The global market for AI-Powered Pathology was valued at US$ 184 million in the year 2023 and is projected to reach a revised size of US$ 382 million by 2030, growing at a CAGR of 11.7% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-33C18563/Global_AI_Powered_Pathology_Market_Research_Report_2024?utm_source=openpr&utm_medium=referral
By Type
• Automated Image Analysis
• Disease Classification
• Predictive Modeling
By Application
• Hospital
• Diagnostic Centers
• Laboratories & Research Institutes
Key Companies
Indica Labs, Aignostics, Deep Bio, Mindpeak, Paige AI, DoMore Diagnostics, Visiopharm, Sonrai Analytics, Stratipath,…
AI In Clinical Trials Market Size, Revenue Share, Insights & Future Outlook
AI In Clinical Trials Market Size
The global market for AI In Clinical Trials was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29K15279/Global_AI_In_Clinical_Trials_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral
By Type
• Software
• Service
By Application
• Pharmaceutical and Biotechnology Companies
• Contract Research Organization
Key Companies
Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC,…
Forensic Accounting Services Market Size, Revenue Share, Insights & Future Outlo …
Forensic Accounting Services Market
The global Forensic Accounting Services market was valued at US$ 19930 million in 2022 and is anticipated to reach US$ 31160 million by 2029, witnessing a CAGR of 7.7% during the forecast period 2023-2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1E9323/Global_Forensic_Accounting_Services_Market_Size_Status_and_Forecast_2022?utm_source=openpr&utm_medium=referral
In general, forensic accounting services entail using the specialized expertise and investigative abilities that CPAs possess to gather, examine, and assess the evidence as well as to interpret and convey conclusions…
Dental Anesthesia Market Size, Revenue Share, Insights & Future Outlook
Dental Anesthesia Market
The global market for Dental Anesthesia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8V13175/Global_Dental_Anesthesia_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral
By Type
• Articaine
• Lidocaine
• Mepivacaine
• Bupivacaine
• Prilocaine
• Others
By Application
• Carpool/Cartridges
• Ampoules
• Vials
Key Companies
Laboratorios Inibsa, Pierre Pharma, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply, Fresenius-Kabi
The Dental Anesthesia Market is experiencing steady market growth as dental care…
More Releases for Commercializing
Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 202 …
According to Market Study Report, Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market provides a comprehensive analysis of the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Commercializing Biomarkers…
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Mar …
This new report by Eon Market Research, titled “Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry at a global as well as regional and country level. Key facts analyzed in this report include the Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size by players, regions, product types and end…
Commercializing Biomarkers Market Research Report 2018 to 2026
In this report, the key data information like sales, revenue are market share, growth rate (CAGR) are the most important contents. We focus these key data by top manufacturers, regions, product type and applications. History data from 2014 to 2018, and projected out to the year 2026. The forecast data is based on the history data in the past several years.
This report includes the estimation of market size for value…
Asthma - Identifying and Commercializing First-in-Class Innovation | Latest Mark …
Researchmoz added Most up-to-date research on "Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation" to its huge collection of research reports.
Analysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough…
Frontier Pharma: Pancreatic Cancer - Identifying And Commercializing First-In-Cl …
Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market.
A highly active pancreatic cancer pipeline contains an array of products with varying molecule types and mechanisms…
Frontier Pharma: Psoriasis - Identifying And Commercializing First-In-Class Inno …
The oncology therapy area comprises a large and diverse range of indications, encompassing virtually all sites and tissues in the human body. These indications are the leading cause of death in economically developed countries and the second-leading cause of death in developing countries and present a major global health burden. Across the pharmaceutical industry as a whole, the oncology pipeline is far larger than any other therapy area, with 6,484…
